Generex Biotechnology acquires surgical supplier, distributor for $1M: 3 notes

Mackenzie Garrity -   Print  |

Generex Biotechnology Corp. signed a letter to purchase Medisource Partners, an FDA-registered distributor.

Three notes:

1. Medisource Partners supplies and distributes bone grafts and biologics from a range of companies.

2. Per the agreement, Generex will acquire all of Medisource Partners' assets, including business operations, accounts receivable and inventory, contracts and real estate.

3. The biotechnology company will acquire Medisource Partners for $1 million worth of its stock, in addition to cash and stock considerations for achieving certain sales and projections.

More articles on biologics:
SpinalCyte earns international patent for biologic product: 3 insights
DiscGenics' cell therapy passes safety review of first-in-human trial: 5 things to know
3 things to know about JRF Ortho

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers